- Home
- INM vs NVNO Comparison
INM vs NVNO Comparison
Compare INM & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INM | NVNO |
|---|---|---|
| Founded | 1981 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 6.8M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INM | NVNO |
|---|---|---|
| Price | $1.30 | $11.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 66.3K | 15.3K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.68 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,942,633.00 | $31,243.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $140.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $0.30 |
| 52 Week High | $2.50 | $13.44 |
Technical Indicators
Market Signals| Indicator | INM | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 53.08 |
| Support Level | $1.03 | $9.96 |
| Resistance Level | $1.40 | $11.40 |
| Average True Range (ATR) | 0.08 | 0.73 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 5.97 | 62.91 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.